BioSpace News Archive

Regenerative medicine is a part of translational research in the fields of molecular biology and tissue engineering.

Responses in 6 out of 9 patients evaluated provide exciting evidence that BI-1206 has the potential to restore activity of rituximab in non-Hodgkin’s lymphoma patients who have relapsed after treatment with rituximab

Collaboration to evaluate the clinical utility of the high throughput bead assisted mass spectrometry (BAMS™) test for SARS-CoV-2 infection developed with Adeptrix

VivaQuant , a digital health company with powerful technology to accurately and efficiently identify and report cardiac arrhythmias, is proud to announce launch of the RX-1 mini .

Can-Fite BioPharma Ltd . (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today published a webinar on Namodenoson in the treatment of NASH hosted by Can-Fite CEO Dr. Pnina Fishman and featuring Dr. Stephen Harrison, a Key Opinion Leader (KOL) in the treatment of non-alcoholic steatohepatitis

The American Professional Society of ADHD and Related Disorders (“APSARD”), a professional organization focused on improving outcomes for individuals with ADHD and their families, and Tris Pharma, Inc. (